Cara Therapeutics (NQ: CARA )

18.51 USD +0.46 (+2.55%)

Streaming Delayed Price Updated: 1:19 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	288,862
Open	18.06
Bid (Size)	18.50 (3)
Ask (Size)	18.51 (1)
Prev. Close	18.05
Today's Range	18.04 - 18.70
52wk Range	8.880 - 19.13
Shares Outstanding	33,874,770
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Pruritus in Patients with Notalgia Paresthetica

January 11, 2021

Expands clinical development of Oral KORSUVA™ into neuropathic pruritus

Cara Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 06, 2021

Performance

YTD	+22.83%	+22.83%
1 Month	+22.18%	+22.18%
3 Month	+41.51%	+41.51%
6 Month	+4.69%	+4.69%
1 Year	+10.18%	+10.18%

More News

Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus

December 28, 2020

SWK Holdings' Subsidiary, Enteris BioPharma, Receives Second Milestone Payment from Cara Therapeutics

December 24, 2020

CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors

December 22, 2020

Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus

December 02, 2020

Cara Therapeutics to Present at Multiple Upcoming Investor Conferences

November 11, 2020

SAB Biotherapeutics Announces New Appointments to its Board of Directors

December 16, 2020

Cara Therapeutics Reports Third Quarter 2020 Financial Results

November 09, 2020

Analysts Anticipate XPH Will Reach $67

January 14, 2021

Noteworthy Wednesday Option Activity: MPC, XPO, CARA

January 06, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.